The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Red Biotechnology Market Research Report 2025
Synopsis
Red biotechnology is also known as biopharmaceuticals. It involves the application of biotechnology to produce medicine and drugs.
The global Red Biotechnology market was valued at US$ 275370 million in 2023 and is anticipated to reach US$ 358800 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
North American market for Red Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Red Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Red Biotechnology in Biopharmaceutical Production is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Red Biotechnology include F. Hoffmann-La Roche, Amgen, Gilead Sciences, CSL and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Red Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Red Biotechnology.
Report Scope
The Red Biotechnology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Red Biotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Red Biotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
Amgen
Gilead Sciences
CSL
Pfizer
Segment by Type
Antibody
Nucleic Acid
Protein
Other
Segment by Application
Biopharmaceutical Production
Gene Therapy
Pharmacogenomics and Genetic Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Red Biotechnology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Red biotechnology is also known as biopharmaceuticals. It involves the application of biotechnology to produce medicine and drugs.
The global Red Biotechnology market was valued at US$ 275370 million in 2023 and is anticipated to reach US$ 358800 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
North American market for Red Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Red Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Red Biotechnology in Biopharmaceutical Production is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Red Biotechnology include F. Hoffmann-La Roche, Amgen, Gilead Sciences, CSL and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Red Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Red Biotechnology.
Report Scope
The Red Biotechnology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Red Biotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Red Biotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
Amgen
Gilead Sciences
CSL
Pfizer
Segment by Type
Antibody
Nucleic Acid
Protein
Other
Segment by Application
Biopharmaceutical Production
Gene Therapy
Pharmacogenomics and Genetic Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Red Biotechnology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Red Biotechnology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody
1.2.3 Nucleic Acid
1.2.4 Protein
1.2.5 Other
1.3 Market by Application
1.3.1 Global Red Biotechnology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Production
1.3.3 Gene Therapy
1.3.4 Pharmacogenomics and Genetic Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Red Biotechnology Market Perspective (2019-2030)
2.2 Red Biotechnology Growth Trends by Region
2.2.1 Global Red Biotechnology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Red Biotechnology Historic Market Size by Region (2019-2024)
2.2.3 Red Biotechnology Forecasted Market Size by Region (2025-2030)
2.3 Red Biotechnology Market Dynamics
2.3.1 Red Biotechnology Industry Trends
2.3.2 Red Biotechnology Market Drivers
2.3.3 Red Biotechnology Market Challenges
2.3.4 Red Biotechnology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Red Biotechnology Players by Revenue
3.1.1 Global Top Red Biotechnology Players by Revenue (2019-2024)
3.1.2 Global Red Biotechnology Revenue Market Share by Players (2019-2024)
3.2 Global Red Biotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Red Biotechnology Revenue
3.4 Global Red Biotechnology Market Concentration Ratio
3.4.1 Global Red Biotechnology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Red Biotechnology Revenue in 2023
3.5 Red Biotechnology Key Players Head office and Area Served
3.6 Key Players Red Biotechnology Product Solution and Service
3.7 Date of Enter into Red Biotechnology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Red Biotechnology Breakdown Data by Type
4.1 Global Red Biotechnology Historic Market Size by Type (2019-2024)
4.2 Global Red Biotechnology Forecasted Market Size by Type (2025-2030)
5 Red Biotechnology Breakdown Data by Application
5.1 Global Red Biotechnology Historic Market Size by Application (2019-2024)
5.2 Global Red Biotechnology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Red Biotechnology Market Size (2019-2030)
6.2 North America Red Biotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Red Biotechnology Market Size by Country (2019-2024)
6.4 North America Red Biotechnology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Red Biotechnology Market Size (2019-2030)
7.2 Europe Red Biotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Red Biotechnology Market Size by Country (2019-2024)
7.4 Europe Red Biotechnology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Red Biotechnology Market Size (2019-2030)
8.2 Asia-Pacific Red Biotechnology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Red Biotechnology Market Size by Region (2019-2024)
8.4 Asia-Pacific Red Biotechnology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Red Biotechnology Market Size (2019-2030)
9.2 Latin America Red Biotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Red Biotechnology Market Size by Country (2019-2024)
9.4 Latin America Red Biotechnology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Red Biotechnology Market Size (2019-2030)
10.2 Middle East & Africa Red Biotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Red Biotechnology Market Size by Country (2019-2024)
10.4 Middle East & Africa Red Biotechnology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Detail
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Red Biotechnology Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Red Biotechnology Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Red Biotechnology Introduction
11.2.4 Amgen Revenue in Red Biotechnology Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Red Biotechnology Introduction
11.3.4 Gilead Sciences Revenue in Red Biotechnology Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 CSL
11.4.1 CSL Company Detail
11.4.2 CSL Business Overview
11.4.3 CSL Red Biotechnology Introduction
11.4.4 CSL Revenue in Red Biotechnology Business (2019-2024)
11.4.5 CSL Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Red Biotechnology Introduction
11.5.4 Pfizer Revenue in Red Biotechnology Business (2019-2024)
11.5.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
